Universitetssjukhuset, Örebro

Örebro 703 62

5 studies enrolling now · 12 studies all time

What they study most

Acute Myocardial Infarction, Atrial Fibrillation, Bronchiectasis, Cardiovascular Risk, Cerebrovascular Disease, Chronic Kidney Disease, Diabetes Mellitus, Type 1, Heart Failure, Intracerebral Haemorrhage, Intracerebral Hemorrhage, Intraventricular Hemorrhage, Leukemia, Myelomonocytic, Chronic

Studies at this site

• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) — Recruiting now
• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
• International Care Bundle Evaluation in Cerebral Hemorrhage Research — Recruiting now
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial — Running, not enrolling
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
• Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack — Completed
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed